About this trial
Evaluation of pelvic floor using 2D and 3D Transperineal Ultrasound
Eligibility criteria
This trial accepts healthy volunteersQualifiers
parous women
Disqualifiers
pregnant women
previous prolapse surgery
Trial population
Parous women who have history of previous delivery either vaginal, operative vaginal or Cesarean section
Trial design
Case-crossover
Cross-sectional
Treatments tested in this trial
Transperineal Ultrasound
Diagnostic testpatients were asked to fill the Pelvic Floor Distress Inventory Questionnaire - Short Form 20. The imaging was performed using a GE Voluson S8 machine. A conventional linear 2D transducer (5-8 MHz) with a field of view of at least 70° was used. For tomographic or multi-slice imaging, a volumetric probe (6-8 MHz) was employed. 2D measures: Bladder neck height ( BN) , Retrovesical angle (RVA) at rest and valsalva, Bladder wall Thickness (BWT), Post micturition Residual volume. For 3D measures Measurements were analyzed offline, assessing the levator hiatal anteroposterior and transverse diameters, Levator Haital area (LHA), Pubovisceral muscle thickness at 3 and 9 o'clock, Pubovisceral muscle length, right and left levator urethral gap and urethral anal distance.
Treatment groups
Trial outcomes
Primary outcomes
Levator Haital area after VD or CS
Increased area means increase vaginal laxity
Sponsors and contacts
Click on the lead sponsor to view all of their trials.